Research summary
Adalank
A vendor-marketed modified Selank derivative. Sellers do not use one consistent chemical identity, and direct indexed evidence for Adalank was not found during this review.
Modified Neuropeptide Research ProductMarketed modified neuropeptideAAsVendor identity variesMWNot establishedCASNot establishedNCAAUnclear
Evidence at a glance
What the research says about Adalank
The Adalank evidence base cited here is 2 sources.
Key findings
What the literature shows
- Adalank is sold as a modified Selank derivative. Sellers do not use one consistent description of the modification.
- A direct indexed Adalank study was not found during this review. This is an evidence gap, not proof that a claimed effect does or does not exist.
- Selank studies are indirect evidence only. They do not establish the identity, stability, efficacy, or safety of Adalank.
Citations
2 peer-reviewed sources
All citations link to the original source (PubMed, journal site, or regulatory filing). Independent research database — no vendor influence on what's cited.
Related research